Utah Medical Products Inc's Cash & cash equivalent grew by 0.14 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Utah Medical Products Inc's Quick Ratio to 42.28 a new company high.

Within Medical Equipment & Supplies industry Utah Medical Products Inc booked the highest Quick Ratio than Utah Medical Products Inc in the second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 73, from total ranking in the first quarter 2026 at 143.

Explain Quick Ratio?
How much Cash & cash equivalents UTMD�s has?
What are UTMD�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

UTMD Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	-8.16 %	-18.94 %	-30.85 %	-12.34 %	-42.78 %
Y / Y Cash & cash equivalent Change	6.51 %	4.9 %	3.35 %	-4.73 %	-7.89 %
Quick Ratio MRQ	42.28	24.94	33.01	27.99	36.46
UTMD's Total Ranking	# 73	# 143	# 70	# 76	# 61
Seq. Current Liabilities Change	-40.94 %	34.91 %	-13.72 %	33.58 %	-47.87 %
Seq. Cash & cash equivalent Change	0.14 %	1.92 %	1.77 %	2.54 %	-1.38 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 1
Healthcare Sector	# 10
Overall Market	# 73

Quick Ratio Statistics
High	Average	Low
42.28	10.65	0.61
(Jun 30 2026)		(Jun 30 2011)

Financial Statements
Utah Medical Products Inc's Current Liabilities	$ 2 Millions	Visit UTMD's Balance sheet
Utah Medical Products Inc's Cash & cash equivalent	$ 88 Millions	Visit UTMD's Balance sheet
Source of UTMD's Sales		Visit UTMD's Sales by Geography

Cumulative Utah Medical Products Inc's Quick Ratio

UTMD's Quick Ratio for the trailling 12 Months

UTMD Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-18.78 %	-26.44 %	-26.61 %	-23.99 %	-24.75 %
Y / Y Cash & cash equivalent TTM Growth	2.38 %	-1.27 %	-5.34 %	-8.67 %	-7.46 %
Quick Ratio TTM	30.84	29.87	27.53	24.93	24.47
Total Ranking TTM	# 2513	# 2456	# 2019	# 2196	# 1939
Seq. Current Liabilities TTM Growth	-1.62 %	-6.72 %	-8.68 %	-3.08 %	-10.9 %
Seq. Cash & cash equivalent TTM Growth	1.58 %	1.22 %	0.84 %	-1.24 %	-2.05 %

Quick ratio ranking by company, industry and sector >> Back to UTMD Financial Strength Comparisons >> Go to Compare UTMD Quick Ratio to its Competitors

On the trailing twelve months basis UTMD Cash & cash equivalent improved by 6.51 % in Q2 2026 year on year, while Current Liabilities plummeted to $2 millions, this led to increase in in Utah Medical Products Inc's Quick Ratio to 30.84, above UTMD average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 159 other companies have achieved higher Quick Ratio than Utah Medical Products Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2456 to 2513.

Explain Quick Ratio?
How much Cash & cash equivalents UTMD�s has?
What are UTMD�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 160
Healthcare Sector	# 761
Within the Market	# 2513

trailing twelve months Quick Ratio Statistics
High	Average	Low
30.84	10.31	0.76
(Jun 30 2026)		(Jun 30 2012)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Utah Medical Products Inc	42.28	$ 87.528 Millions	$ 2.070 Millions
Microbot Medical Inc	34.10	$ 132.596 Millions	$ 3.888 Millions
Global Innovative Platforms Inc.	31.35	$ 0.244 Millions	$ 0.008 Millions
Anteris Technologies Global Corp	14.02	$ 257.385 Millions	$ 18.360 Millions
Heartflow Inc	13.95	$ 615.238 Millions	$ 44.088 Millions
Ceribell Inc	13.13	$ 225.898 Millions	$ 17.200 Millions
Perspective Therapeutics Inc	12.80	$ 467.708 Millions	$ 36.544 Millions
Lemaitre Vascular Inc	12.57	$ 376.240 Millions	$ 29.935 Millions
Mobia Medical Inc	12.24	$ 177.090 Millions	$ 14.472 Millions
Envveno Medical Corporation	11.39	$ 21.486 Millions	$ 1.887 Millions
Pulse Biosciences Inc	9.26	$ 101.620 Millions	$ 10.978 Millions

Date modified: 2026-09-04T10:52:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.